Parkinson's disease device trial at Addenbrooke's Hospital

A instrumentality that could perchance amended the mobility of radical with Parkinson's illness is being trialled connected inpatients astatine a Cambridge hospital.

The CUE1, worn connected the sternum of the chest, delivers vibration and pulses intended to amended centrifugal skills and alleviate stiffness.

It is hoped the device, being trialled astatine Addenbrooke's Hospital, volition besides trim falls.

Addenbrooke's Hospital has bought 10 devices with the assistance of its charitable trust.

They were developed by Cambridge institution Charco Neurotech.

Lucy Jung, its main enforcement officer, said: "The CUE1 has been developed by designers, engineers and clinicians, and offers a novel, non-invasive attack to minimising the symptoms of Parkinson's."

She said it was present "being trialled successful a infirmary mounting for the precise archetypal time".

Dr Alistair Mackett, who specialises successful Parkinson's illness astatine Cambridge University Hospitals Trust, said: "I felt that it was breathtaking to proceedings the CUE1 devices arsenic they person been shown to beryllium harmless with astir nary side-effects, yet perchance adjuvant with mobility and a simplification successful falls.

"In the UK astir 1,000 radical already usage the device. We are the archetypal infirmary successful the satellite to usage them with inpatients.

"The aviator volition let america to cod information and recognize however champion to usage the CUE1 instrumentality successful radical with Parkinson's who person been admitted to hospital."

He said Addenbrooke's Hospital usually had betwixt 20 and 30 inpatients with the illness astatine immoderate 1 time.

"My proposal is that we mightiness beryllium capable to spot an betterment successful mobility, allowing patients to amended enactment successful therapy and hopefully spell location quicker," helium added.